Project Grant HT94252410952
Award Date
11/1/24
Completion Date
10/31/26
Dollars Obligated
$622K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Bloomington, IN 47405, USA
Similar Awards
The Defense Health Agency awarded Trustees of Indiana University, doing business as Indiana University, a $704,674 Project Grant under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop a preclinical model for gene therapy of Fanconi anemia group C. Through this award with a completion date of September 29, 2026, Indiana University will perform research to investigate medical solutions for battlefield conditions by developing a preclinical model for a...
The Trustees of Indiana University received a $950,999 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 2021 through May 2025 to target EZH2-HOTAIR in order to block platinum-induced ovarian cancer stem cell enrichment and reduce recurrence. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the...
The Trustees of Indiana University, doing business as Indiana University Indianapolis (IU Indianapolis), has been awarded a $1,576,423 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This federal grant, awarded on August 1, 2024, will support research to mitigate therapy resistance by combining CDK4/6 and PI3K/mTOR inhibition in pediatric and adolescent/young adult (AYA) osteosarcoma. The research project aims to develop...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $1,188,750.00 to the Trustees of Indiana University (Indiana University) for the project "ANCESTRY-DEPENDENT STROMAL CELL FACTORS IN BREAST CANCER PROGRESSION." The award period runs from January 31, 2025 to January 30, 2028. This research grant supports advanced biomedical investigations aimed at transforming healthcare for military service...
Trustees of Indiana University was awarded a $724,697 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to optimize muscle function in composite tissue injuries with segmental bone defects. The three-year award beginning May 1, 2023 will support Indiana University's research efforts to investigate medical solutions for battlefield injuries involving both soft tissue damage and bone loss. Through this funding,...
The Trustees of Indiana University were awarded a $3,930,678 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2024 to target replication stress in pediatric and young adult osteosarcoma. The Military Medical Research and Development program supports biomedical research to transform military and public health care through innovative solutions. This award...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $713,250 over 3 years to the Trustees of Indiana University (doing business as Indiana University) to conduct research targeting the CENPF-CENPE axis for the prevention and treatment of NF1-associated malignant peripheral nerve sheath tumors. The research aims to develop new approaches for addressing this condition, which impacts military service...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $158,500.00 to support the development of therapeutic strategies for targeting BET proteins and ALK in rare models of embryonal rhabdomyosarcoma with aggressive variants. The award was granted to the Trustees of Indiana University, doing business as Indiana University, and covers the period from September 30, 2024 to September 29, 2026. The funding will...
The Trustees of Indiana University were awarded a $1.3 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 to prevent post-traumatic epilepsy by inhibiting the initiation of innate immune reaction. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care...
The Trustees of Indiana University were awarded a $956,104 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from May 2022 to May 2026 to decipher the role of progesterone in ovarian cancer risk for BRCA mutation carriers. Through this award, Indiana University researchers will investigate medical solutions for the battlefield and transform health care for service members and the...